U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07537231) titled 'A Clinical Study to Evaluate the Absorption, Metabolism, and Excretion of Oral [14C]GS1-144 in Healthy Postmenopausal Female Participants' on April 07.
Brief Summary: This is a single-center, non-randomized, open-label, single-dose clinical PK study in healthy postmenopausal female participants.
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
Healthy Postmenopausal Women
Absorption
Metabolism
Excretion
Intervention:
DRUG: [14C]GS1-144
30 mg/100 µCi [14C]GS1-144, taken orally once
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Published by HT Digital Con...